Form EFFECT Prime Medicine, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 4, 2026 |
| Accession Number: | 0001894562-26-000009 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prime Medicine to Participate in Upcoming Investor Conferences
- INEO Tech Corp. (TSX.V: INEO) (OTCQB: INEOF) Featured in Coverage of the Disruptive Growth & Life Sciences Conference
- Bimergen Energy Corp. (NYSE American: BESS) Featured in Coverage of the Disruptive Growth & Life Sciences Conference
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
